Where does MIRO stock trade?

Miromatrix Medical Inc. (MIRO) is listed on NASDAQ.

What sector and industry is MIRO in?

Miromatrix Medical Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.

When did Miromatrix Medical Inc. go public?

Miromatrix Medical Inc. (MIRO) completed its IPO in 2021.

What are analysts saying about MIRO?

Miromatrix Medical Inc. has had 1 recent analyst action on file. The most recent action was from Craig Hallum: Buy with a $2200.00 price target on 2021-07-19. Recent price targets cluster around $2200.00.

What companies are similar to MIRO?

Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare MIRO side-by-side with any of them on Quantisnow.

How can I track MIRO on Quantisnow?

Quantisnow aggregates Miromatrix Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MIRO to receive live email and push alerts on every new disclosure.

MIRO

NASDAQ

Miromatrix Medical Inc.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2021

$3.40+0.03 (+0.89%)

News25/Ratings1

Latest news

25 items

844d13D/G
SEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)
SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
844d13D/G
SEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)
SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
895dSEC
SEC Form 15-12G filed by Miromatrix Medical Inc.
15-12G - Miromatrix Medical Inc. (0001527096) (Filer)
898d13D/G
SEC Form SC 13D filed by Miromatrix Medical Inc.
SC 13D - Miromatrix Medical Inc. (0001527096) (Subject)
902dSEC
Miromatrix Medical Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update
8-K - Miromatrix Medical Inc. (0001527096) (Filer)
903dSEC
SEC Form EFFECT filed by Miromatrix Medical Inc.
EFFECT - Miromatrix Medical Inc. (0001527096) (Filer)
906dINSIDER
New insider United Therapeutics Corp claimed ownership of 27,419,228 shares (SEC Form 3)
3 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Heine Lisa Wipperman returned 67,413 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Maag Peter returned 58,368 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Erb John L returned 54,201 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Buckman Paul returned 54,201 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Burke William P. Mr. returned 67,413 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Douglas James Michael returned 20,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dINSIDER
Ross Jeffrey James returned 87,500 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Miromatrix Medical Inc. (0001527096) (Issuer)
907dSEC
SEC Form POS AM filed by Miromatrix Medical Inc.
POS AM - Miromatrix Medical Inc. (0001527096) (Filer)
907dSEC
SEC Form S-8 POS filed by Miromatrix Medical Inc.
S-8 POS - Miromatrix Medical Inc. (0001527096) (Filer)
907dSEC
SEC Form S-8 POS filed by Miromatrix Medical Inc.
S-8 POS - Miromatrix Medical Inc. (0001527096) (Filer)
907dSEC
SEC Form SC 14D9/A filed by Miromatrix Medical Inc. (Amendment)
SC 14D9/A - Miromatrix Medical Inc. (0001527096) (Subject)
907dSEC
SEC Form SC TO-T/A filed by Miromatrix Medical Inc. (Amendment)
SC TO-T/A - Miromatrix Medical Inc. (0001527096) (Subject)
907dPR
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix's development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The tender offer expired at one minute after 11:59 p.m., New York City time, on Decem
907dSEC
SEC Form 25-NSE filed by Miromatrix Medical Inc.
25-NSE - Miromatrix Medical Inc. (0001527096) (Subject)
908d13D/G
SEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)
SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
908dSEC
SEC Form SC 14D9/A filed by Miromatrix Medical Inc. (Amendment)
SC 14D9/A - Miromatrix Medical Inc. (0001527096) (Subject)
908dSEC
SEC Form SC TO-T/A filed by Miromatrix Medical Inc. (Amendment)
SC TO-T/A - Miromatrix Medical Inc. (0001527096) (Subject)
909dPR
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. ("Merger Sub"), a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix's development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The tender offer expired at one minute after 11:59 p.m., New York City time, on December 11, 2023. Contine

MIRO FAQ

6 questions

Where does MIRO stock trade?
Miromatrix Medical Inc. (MIRO) is listed on NASDAQ.
What sector and industry is MIRO in?
Miromatrix Medical Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
When did Miromatrix Medical Inc. go public?
Miromatrix Medical Inc. (MIRO) completed its IPO in 2021.
What are analysts saying about MIRO?
Miromatrix Medical Inc. has had 1 recent analyst action on file. The most recent action was from Craig Hallum: Buy with a $2200.00 price target on 2021-07-19. Recent price targets cluster around $2200.00.
What companies are similar to MIRO?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare MIRO side-by-side with any of them on Quantisnow.
How can I track MIRO on Quantisnow?
Quantisnow aggregates Miromatrix Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MIRO to receive live email and push alerts on every new disclosure.